Behavioral and Cognitive Predictors of Persistent Pain and Opioid Misuse in Chronic Pain
Recruiting now
Conditions studied: Chronic Back Pain
In brief
Chronic lower back pain (CLBP) affects approximately 20% of the global population. The study objective is to determine if impulsivity, inhibitory control, drug choice, and/or cognitive distortions predict opioid misuse and disability in patients with chronic pain. This is a prospective consented cross-sectional study characterizing behavioral and cognitive phenotypes using both patient-reported survey measures and cognitive testing. Outcome measures include correlations between impulsivity measures, opioid drug choice responses and cognitive distortion scores, and risk for opioid misuse (Primary outcomes: COMM scores, SOAPPR scores). Secondary outcomes is BPI measurement. A Certificate of Confidentiality will provide additional protections for participants.
Key facts
- Study ID
- NCT06288282
- Run by
- Icahn School of Medicine at Mount Sinai
- People needed
- 130
- Starts
- 2023-12-20
- Expected to finish
- 2025-12-01
- Last updated by the study team
- 2025-06-12
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- With diagnoses related to chronic lower back pain
- Age above 18yrs
- Non pregnant
You may not qualify if…
- Cancer pain
Where it is running
- Mount Sinai Pain management centers — New York, New York, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.